Skip to main content
. 2016 Aug 24;39(9):537–543. doi: 10.1002/clc.22563

Table 1.

Characteristics of Studies Included in the Meta‐analysis

First Author and Year Location Study Design Patients With AF/Total Patients, N Definition of AF Methods of AF Detection Measurement of Vitamin D Winter or Spring Season Definition of Vitamin D Deficiency Follow‐up Quality Score
Rienstra 2011 United States Prospective cohort 425/2930 New‐onset AF ECGs (clinic visits, external physician visits, Holter monitoring, or hospital records) A competitive protein‐binding assay (Original cohort) and a radioimmunoassay (Offspring cohort) 1160 (winter) 25(OH)D <17 ng/mL for the Original cohort and 13.4 ng/mL for the Offspring cohort 9.9 ± 4.0 years 8
Chen 2014 China Case control 162/322 Nonvalvular persistent AF ECG Chemiluminescence assay 322 (spring) <20 ng/mL NA 8
Demir 2014 Turkey Case control 102/202 Nonvalvular persistent AF NA Electrochemiluminescence method 202 (winter) NA NA 8
Ozcan 2015 Turkey Case control 137/227 New‐onset AF ECG or ambulatory Holter monitoring Chemiluminescent immunoassay 227 (winter and spring) <20 ng/mL NA 8
Vitezova 2015 Netherlands Prospective cohort 263/3395 New‐onset AF ECG Electrochemiluminescence immunoassay NA <50 nmol/L (20 ng/mL) 12.0 years 8
Mathew 2014 (MESA/CHS) United States Prospective cohort 291/6398, 229/1350 New‐onset AF Systematic reviews of hospital discharge diagnoses, inpatient and outpatient physician claims data, and study ECGs Mass spectrometry NA NA 7.7 years, 8.0 years 8, 8
Alonso 2016 United States Prospective cohort 1866/12 303 New‐onset AF ECGs performed during study examinations, hospital discharge codes, and death certificates Mass spectrometry NA <20 ng/mL 21 years 9
Belen 2016 Turkey Case control 96/180 Chronic AF NA High‐performance liquid chromatography All were examined at similar seasonal periods NA NA 8

Abbreviations: AF, atrial fibrillation; CHS, Cardiovascular Health Study; ECG, electrocardiogram; MESA, Multi‐Ethnic Study of Atherosclerosis; NA, not applicable.